Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 SGD | -1.82% | 0.00% | -5.26% |
Apr. 09 | Hyphens Pharma’s Attributable Profit Narrows in 2023 | MT |
Apr. 09 | Hyphens Pharma International Limited Proposes Final Tax Exempt (One-Tier) Dividend | CI |
Sales 2023 | 171M 125M | Sales 2024 * | 183M 134M | Capitalization | 83.36M 61.23M |
---|---|---|---|---|---|
Net income 2023 | 8M 5.88M | Net income 2024 * | 11M 8.08M | EV / Sales 2023 | 0.52 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.46 x |
P/E ratio 2023 |
10.3
x | P/E ratio 2024 * |
7.51
x | Employees | 355 |
Yield 2023 |
15.6% | Yield 2024 * |
3.93% | Free-Float | 18.14% |
1 day | -1.82% | ||
Current month | +1.89% | ||
1 month | -5.26% | ||
3 months | -3.57% | ||
6 months | -3.57% | ||
Current year | -5.26% |
Managers | Title | Age | Since |
---|---|---|---|
See Wah Lim
CEO | Chief Executive Officer | 56 | 97-12-31 |
Flora Zhang
DFI | Director of Finance/CFO | - | 22-12-31 |
Chief Operating Officer | 59 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eng Leng Ng
BRD | Director/Board Member | 59 | 18-04-22 |
Kiat Chan
BRD | Director/Board Member | 52 | 20-11-04 |
See Wah Lim
CEO | Chief Executive Officer | 56 | 97-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.27 | -1.82% | 105,000 |
24-04-18 | 0.275 | 0.00% | 70,000 |
24-04-17 | 0.275 | +1.85% | 28,000 |
24-04-16 | 0.27 | 0.00% | 40,000 |
24-04-15 | 0.27 | 0.00% | 25,000 |
Delayed Quote Singapore S.E., April 18, 2024 at 11:25 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.26% | 61.26M | |
+13.36% | 68.97B | |
+7.33% | 26.32B | |
-2.79% | 7.92B | |
-24.02% | 7.61B | |
-0.18% | 4.5B | |
+21.83% | 4.49B | |
-2.28% | 3.95B | |
-3.51% | 3.85B | |
+25.02% | 3.73B |
- Stock Market
- Equities
- 1J5 Stock